Skip to main content
Immunology logoLink to Immunology
. 2020 Dec 20;162(3):262–267. doi: 10.1111/imm.13290

NLRP9 in innate immunity and inflammation

Breanne Mullins 1, Jueqi Chen 1,
PMCID: PMC7884643  PMID: 33283292

NLRP9, one of the less‐characterized NLR members, has been shown to initiate inflammasome activation in host defence against rotavirus infection. This review highlights the latest progress in characterization of the role of NLRP9 in infectious and inflammatory diseases. The recent crystallographic and biochemical studies on NLRP9 have also raised some important questions remained to be fully investigated.

graphic file with name IMM-162-262-g002.jpg

Keywords: inflammasome, intestine, NLR, NLRP9, rotavirus

Summary

The nucleotide‐binding domain leucine‐rich repeat containing receptors (NLRs) are a family of evolutionarily conserved proteins. Several members of NLRs, notably NLRP1, NLRP3 and NLRC4, are able to form cytosolic oligomeric signalling platforms termed inflammasomes to mediate immune response towards pathogens, damage and stress. However, the functions of many NLRs still remain elusive. In the past few years, a couple of less‐characterized NLR members are emerging as important signalling molecules with fundamental functions in host defence and inflammation. Among them, NLRP9 is an NLR originally proposed to be expressed and function solely in the reproductive system. Recent evidence has suggested that NLRP9 is also capable of initiating inflammasome formation in the intestine to restrict replication and damage brought by rotavirus infection. Here, we highlight the latest progress in characterization of the role of NLRP9 in infectious and inflammatory diseases, as well as the newest crystallographic and biochemical studies on NLRP9. Finally, we discuss some important questions remained to be answered regarding the molecular and cellular mechanisms governing NLRP9's function in innate immunity and inflammation.


Abbreviations

NLR

nucleotide‐binding domain leucine‐rich repeat containing receptors

NOD

nucleotide‐binding oligomerization domain

PRR

pattern recognition receptors

PAMPs

pathogen‐associated molecular patterns

DAMPs

damage‐associated molecular patterns

NBD

nucleotide‐binding‐domain

NLRP

NLR family pyrin domain containing

TLR

Toll‐like receptor

RLR

RIG‐I‐like receptor

ALR

AIM2‐like receptor

CLRs

C‐type lectin receptors

PYD

pyrin domain

CARD

carboxy‐terminal caspase recruitment domain

IL

interleukin

dsRNA

double‐stranded RNA

DHX

DExH‐box helicase

INTRODUCTION

The nucleotide‐binding domain leucine‐rich repeat containing receptors (NLRs), also known as nucleotide‐binding oligomerization domain‐like receptors (NOD‐like receptors), are an ancestral group of germline‐encoded intracellular proteins, of which many serve as pattern recognition receptors (PRRs) to detect a wide range of pathogen‐associated molecular patterns (PAMPs), damage‐associated molecular patterns (DAMPs) and other varieties of environmental stress. 1 NLRs have been discovered in a broad spectrum of species including those in the plant kingdom, all of which evolved from ancient nucleotide‐binding‐domain (NBD)‐containing proteins. 2 Plant and animal NLRs are heavily involved in intracellular immune surveillance of invading pathogens via conserved principles of activation shared by domains commonly found in this family. It has been reported that at least 22 and 34 NLR genes are encoded in the human and mouse genome, respectively. 3 NLR proteins are characterized by a centrally located NAIP, CIITA, HET‐E and TP1 (NACHT) domain involved in nucleotide‐binding and oligomerization. The NLR protein family can be further divided into several subfamilies based on the different amino‐terminal effecter domains. The ones containing a pyrin domain (PYD) at the N‐terminus are named NLR family pyrin domain containing (NLRP) proteins. 4 To date, 14 human and 20 murine NLRPs have been identified, 5 , 6 yet only a few such as NLRP1 and NLRP3 have been extensively studied. Recent years have witnessed an intensive effort in elucidating the functions and characteristics of the less well‐known NLRs. In this review, we focus on the recent advances in our understanding of NLRP9, one of the least studied NLRs, in innate immune and inflammatory responses, as well as the implications in health and disease.

NLRP9 ISOFORMS AND REPRODUCTIVE FUNCTIONS

NLRP9 is one of the three NLRPs (together with NLRP1 and NLRP4) that have undergone lineage‐specific duplications in rodents. While humans only have one NLRP9 gene (hNLRP9), mice harbour three isoforms (mNLRP9a, mNLRP9b and mNLRP9c). 7 Together with NLRP4, NLRP5, NLRP8 and NLRP14, NLRP9 belongs to a subgroup of reproduction‐related NLRPs exclusively or mainly expressed in reproductive organs. 7 , 8 With the exception of NLRP14, all the human NLRPs with implicated functions in reproductive systems are tandemly distributed on chromosome 19, indicating that a series of tandem duplication events may have given rise to these NLR genes, and their functions may be closely related yet specified. 4 , 7

The most well‐characterized NLR involved in mammalian reproduction is NLRP5 (also known as MATER). Female NLRP5‐deficient mice were unable to support embryonic development beyond the two‐cell stage and therefore were sterile, indicating that NLRP5 is a maternal effect gene essential for early embryogenesis. 9 In contrast, the exact functions of NLRP9 in reproductive systems have remained mysterious until recently. Early studies have proposed that human, murine and bovine NLRP9 were selectively expressed in oocytes, ovaries and testes, 10 , 11 , 12 , 13 , 14 , 15 and as a result, NLRP9 has been implicated to function in preimplantation embryo development. 16 While neither simultaneous knockout of NLRP9a and NLRP9c nor single knockdown of NLRP9b affected early embryonic development in mice, 17 , 18 a recent study discovered that female mice deficient in all three isoforms of NLRP9 had defective blastocyst development and increased lethality in the preimplantation embryos. 19 In vitro culture also showed that fertilized eggs from these female mice had developmental arrest at the two‐cell stage. In contrast, those from female mice with two NLRP9 isoforms depleted were able to develop into blastocysts, although they all exhibited varying degrees of developmental delay. 19 This indicates functional redundancy for NLRP9a, NLRP9b and NLRP9c in embryogenesis of mice. It remains to be determined how exactly NLRP9 isoforms affect cell division during embryonic development and, importantly, whether mutations in human NLRP9 are linked to infertility.

NLRP9 INFLAMMASOME ASSEMBLY AND ITS INDUCTION BY ROTAVIRUS INFECTION

The mammalian innate immune system comprises five major families of PRRs including Toll‐like receptors (TLRs), RIG‐I‐like receptors (RLRs), AIM2‐like receptors (ALRs), C‐type lectin receptors (CLRs) and NLRs. 20 Certain members of ALRs (e.g. AIM2) and NLRs (e.g. NLRP1, NLRP3 and NLRC4) oligomerize upon ligand stimulation, before recruiting downstream components to assemble intracellular multimeric protein complexes known as inflammasomes. While NLRP1 and NLRC4 can directly recruit the effector cysteine protease caspase‐1, most inflammasome sensors first recruit the adaptor protein ASC (also known as PYCARD). 21 ASC is a bipartite protein consisting of an amino‐terminal PYD and a carboxy‐terminal caspase recruitment domain (CARD). ASC binds to the upstream inflammasome sensors through homotypic PYD‐PYD interaction and to the downstream effector caspase‐1 via CARD–CARD interaction. Besides serving as a bridge, ASC also amplifies the signal through prion‐like polymerization to assemble filaments with fast kinetics. 22 , 23 After recruitment, caspase‐1 undergoes proximity‐induced autoproteolytic cleavage, releasing the catalytic subunits p20 and p10 to assemble into mature caspase‐1. The biologically active form of caspase‐1 not only processes and induces the secretion of proinflammatory cytokines including interleukin (IL)‐1β and IL‐18, but also cleaves the pore‐forming protein gasdermin D (GSDMD) to trigger a specific form of proinflammatory cell death termed pyroptosis. 24 With the exceptions of NLRP1 and NLRP10, all the other 12 NLRP members including NLRP9 share similar domain structure: an amino‐terminal PYD, a middle NACHT domain and a carboxy‐terminal leucine‐rich repeat (LRR) region. However, for a long time it has remained unclear whether NLRP9 can initiate inflammasome formation similar to NLRP3, especially as NLRP9 was previously reported to express predominantly in reproductive organs. 12 , 13 , 14 , 15

Recent evidence, however, found that NLRP9b in mice, but not its closely related isoforms NLRP9a or NLRP9c, was one of the only two NLRPs (the other being NLRP6) highly expressed in the ileum. 25 In addition, caspase‐1 cleavage was detected in ileal tissues from mice challenged with rotavirus. 25 Rotavirus is a genus of double‐stranded RNA viruses that infect the small intestine and cause diarrhoeal disease, resulting in over 200,000 deaths annually worldwide. 26 Supporting the hypothesis that NLRP9b initiates inflammasome activation upon rotavirus infection, mice deficient in NLRP9b, ASC or caspase‐1 showed elevated viral load and more severe pathogenesis compared with wild‐type mice. 25 Unlike NLRP3, which is mainly expressed in immune cells of the myeloid lineage, 27 NLRP9b expression was enriched in intestinal epithelial cells but not the neighbouring lymphocytes. 25 In concordance with this observation, conditional knockout of NLRP9b in intestinal epithelial cells also caused higher susceptibility to rotavirus infection, 25 indicating the protective function of NLRP9b is executed in epithelial cells that line the intestine. Together, these results established NLRP9b as an inflammasome sensor in response to rotavirus in the intestine (Figure 1).

Figure 1.

Figure 1

Rotavirus infection induces NLRP9 inflammasome activation. Upon rotavirus infection in the intestinal epithelial cells, the RNA helicase DHX9 binds to viral RNA derived from rotavirus, before forming a complex with NLRP9 via mechanisms still not fully understood. Activated NLRP9 then recruits the downstream adaptor ASC through PYD‐PYD interaction. ASC in turn interacts with the cysteine protease caspase‐1 through CARD–CARD interaction. Caspase‐1 undergoes autocleavage to assemble into mature caspase‐1 comprising p20 and p10 subunits. The active form of caspase‐1 cleaves pro‐IL‐18 into IL‐18 to facilitate its secretion, triggering proinflammatory responses. Whether caspase‐1 also processes pro‐IL‐1β in the context of rotavirus infection is still unclear. Caspase‐1 also leads to activation of GSDMD, which forms pores on the plasma membrane to induce the proinflammatory cell death mode termed pyroptosis.

The composition of microbiota, which also colonize human intestines, was not significantly altered in mice lacking NLRP9b, suggesting that NLRP9b does not execute its antiviral role indirectly through influencing microbiota. 25 The authors then investigated which downstream signalling of inflammasome is critical for defence against rotavirus. IL‐18 but not IL‐1β was detected in intestinal epithelial cells, prompting the authors to examine the contribution of IL‐18 in restricting rotavirus infection. Surprisingly, although IL‐18 secretion induced by rotavirus challenge was impaired by NLRP9b deficiency, IL‐18‐deficient mice did not exhibit increased susceptibility compared with control mice, 25 contrary to the previous report that the presence of IL‐18 helped eliminate rotavirus infection. 28 On the other hand, it remains to be examined whether IL‐1β level in intestines could be induced upon rotavirus infection, as has been shown in NLRP3 inflammasome activation 27 and whether this proinflammatory cytokine contributes to NLPR9b‐mediated protection against enteric viruses.

In contrast, mice lacking GSDMD were more vulnerable to rotavirus infection than wild‐type mice, 25 implicating that pyroptosis plays a predominant role in rotavirus surveillance, likely by eliminating infected cells. Because rotavirus infection is known to cause diarrhoeal disease through epithelial damage, 29 further studies are required to understand how cells killed or damaged by NLRP9b‐dependent pyroptosis can be repaired or replenished in a timely manner to prevent enhanced pathogenesis.

MOLECULAR AND STRUCTURAL MECHANISMS OF NLRP9 ACTIVATION

Although NLRP9b did not bind to viral RNA directly, it co‐precipitated with short double‐stranded RNA (dsRNA) stretches. 25 DExH‐box helicase (DHX)9, an RNA helicase that preferentially bound to short dsRNA, was proposed as the intermediate protein bringing NLRP9b and viral RNA into the same complex. 25 How DHX9 distinguishes between viral RNA and host RNA to avoid triggering autoinflammatory response in this context is still not fully understood. 30 Moreover, the exact molecular mechanisms underlying NLRP9b inflammasome formation still require further dissection. Identifying the regions/domains in DHX9 and NLRP9b that mediate the complex formation, as well as examining the subcellular localization of NLRP9b inflammasome in rotavirus‐infected intestinal cells or organoids, may unravel the exact molecular and cellular mechanisms governing the initiation of this inflammasome.

Two recent studies 31 , 32 have solved the crystal structure of PYD derived from human NLRP9 (hNLRP9PYD), highlighting the similarities and differences of NLRP9 with other NLRs. As the common module shared by all NLR proteins, PYD is not only indispensable for the interaction between NLRs and ASC, but is also crucial for signal amplification of inflammasome pathways through its nucleation‐driven polymerization. The overall structure of hNLRP9PYD assumes an antiparallel six‐helical bundle fold 31 , 32 that is typical for the death domain superfamily that PYD belongs to. 33 Surprisingly, hNLRP9PYD exited as monomers instead of a higher oligomeric filament structure in solution. 31 , 32 Consistently, hNLRP9PYD did not self‐polymerize or promote speck formation of ASC when overexpressed in HEK293 T cells. 31 This is in great contrast to PYDs in other inflammasome sensors including NLRP3, NLRP6 and AIM2, all of which could oligomerize to act as the nucleation seed for ASC filament assembly. 22 , 34 , 35 , 36 Further analysis suggested that monomeric hNLRP9PYD already exists in a conformation compatible with higher oligomeric filament formation, 31 , 32 suggesting that certain autoinhibitory mechanism may prevent its oligomerization and activation. Two hypothetical mechanisms have been proposed to explain the inability of hNLRP9PYD to self‐polymerize. First, a kinked N‐terminal loop is oriented towards the interior of the helical bundle and may block interactions between hNLRP9PYD molecules. 32 Second, charge inversions in the proposed interfaces of hNLRP9PYD molecules may cause repulsive effect for intra‐ and inter‐strand interactions. 31 Nevertheless, it cannot be ruled out that other domains of NLRP9 help drive the polymerization of PYD to recruit ASC. Although it still remains extremely difficult to solve structures of full‐length NLRs, rapid technology advances on structural biology may eventually overcome the challenges and fuel our understanding of how exactly NLRs, including NLRP9, co‐ordinate their different domains in triggering innate immune responses. In addition, the presence of the DHX9‐RNA complex may license NLRP9 to assemble an inflammasome complex, and whether the structure of murine NLRP9b may differ from its human homolog has yet to be fully investigated. Indeed, overexpressed full‐length human NLRP9 was shown to interact with ASC when reconstituted in HEK293 T cells in a rotavirus infection‐dependent manner. 25

NLRP9 IN OTHER INFLAMMATORY DISEASES

A recent study also implicated NLRP9b's role in a mouse model of acute lung injury. 37 NLRP9b‐deficient mice showed lower neutrophilic inflammation, more protected alveolar architecture and subsequently higher survival rate compared with wild‐type mice. Elevated levels of proinflammatory cytokines, apoptosis, NF‐κB activation and oxidative stress have all been proposed as responsible for the detrimental role of NLRP9b, 37 although their exact contributions still require further studies.

NLRP9 is also associated with a number of other inflammatory diseases, including systemic‐onset juvenile idiopathic arthritis, 38 multiple sclerosis, 39 familial late‐onset Alzheimer's disease, 40 urothelial carcinoma 41 and Helicobacter pylori infection. 42 Genetic deletion of NLRP9 in animal models and further mechanistic studies are still underway for us to fully understand the roles of NLRP9 in these inflammatory disorders.

CONCLUSIONS AND PERSPECTIVES

Although the importance of NLR proteins in innate immunity and inflammation has been known for more than 15 years, only recently have we started to appreciate the roles of the less‐studied NLRs in host defence and other inflammatory disorders. The discovery of NLRP9b as an inflammasome sensor in response to rotavirus infection and the recent characterization of hNLRP9PYD structure have raised a number of new questions, including the ones discussed above and a few highlighted below. Addressing these questions would provide substantial insights into the functions of NLRP9 and the future design of novel therapeutic approaches targeting related diseases.

Does human NLRP9 also oligomerize to form an inflammasome upon rotavirus infection? Although hNLRP9 was also highly expressed in human intestinal epithelial cells, 25 whether rotavirus infection triggers inflammasome formation and caspase‐1 cleavage is still unclear. Given that the amino acid composition of hNLRP9 only shares less than 50% similarity with that of mNLRP9 isoforms, further investigation is essential to test whether they are different in ligand recognition. Another intriguing question is whether mNLRP9a and mNLRP9c, which are not detected in intestines, are involved in inflammasome activation in other organs and tissues.

How does NLRP9b synergize with other PRRs in clearing rotavirus? NLRP6 is the only other NLRP highly enriched in intestine. 25 Interestingly, NLRP6‐deficient mice exhibited increased viral loads in the gastrointestinal tract when challenged with rotavirus 25 or encephalomyocarditis virus. 43 Analogous to how NLRP9b works in concert with DHX9 to detect viral RNA, NLRP6 requires another RNA helicase DHX15 to interact with viral RNA. 43 Interestingly, while NLRP9b preferred to form complexes with low molecular weight RNA, NLRP6 favoured high molecular weight RNA. 25 It thus remains to be explored which type of viral RNA is predominantly present in rotavirus‐infected epithelial cells in the small intestine, and whether NLRP9b, NLRP6 and other PRRs that were reported to respond to rotavirus, 26 work synergetically to elicit immune responses towards rotavirus invasion. Besides rotavirus, whether other pathogens in the gastrointestinal tract activate the NLRP9 inflammasome also requires deeper examination.

The recent breakthrough regarding NLRP9's role in inflammasome signalling came from a careful examination of its expression pattern. 25 Besides intestines, NLRP9 has been reported in lung tissue, 37 brain endothelial cells, 44 brain pericytes, 45 brain macrophages and microglia. 39 As the field moves forward, a thorough re‐examination of the localization of NLRP9 and other less well‐studied NLRs may provide hints on their potential functions in different tissues and organs, as well as how they contribute to infectious and inflammatory diseases.

CONFLICT OF INTEREST

The authors declare no conflict of interest.

ACKNOWLEDGEMENTS

J.C. is supported by the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) that funds the Institute for Translational Medicine (ITM) (5UL1TR002389‐02).

OTHER ARTICLES PUBLISHED IN THIS REVIEW SERIES

Enigmatic inflammasomes. Immunology 2021, 162: 249‐251.

MHC class I transactivator NLRC5 in host immunity, cancer and beyond. Immunology 2021, 162: 252‐261.

NLR in eXile: Emerging roles of NLRX1 in immunity and human disease. Immunology 2021, 162: 268‐280.

The NLRP6 inflammasome. Immunology 2021, 162: 281‐289.

DATA AVAILABILITY STATEMENT

No data have been generated.

REFERENCES

  • 1. Xue Y, Enosi Tuipulotu D, Tan WH, Kay C, Man SM. Emerging Activators and Regulators of Inflammasomes and Pyroptosis. Trends Immunol. 2019; 40(11):1035–52. [DOI] [PubMed] [Google Scholar]
  • 2. Jones JD, Vance RE, Dangl JL. Intracellular innate immune surveillance devices in plants and animals. Science 2016; 354(6316):aaf6395. [DOI] [PubMed] [Google Scholar]
  • 3. Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol. 2012; 28:137–61. [DOI] [PubMed] [Google Scholar]
  • 4. Van Gorp H, Kuchmiy A, Van Hauwermeiren F, Lamkanfi M. NOD‐like receptors interfacing the immune and reproductive systems. FEBS J. 2014; 281(20):4568–82. [DOI] [PubMed] [Google Scholar]
  • 5. Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol. 2003; 4(2):95–104. [DOI] [PubMed] [Google Scholar]
  • 6. Martinon F, Gaide O, Petrilli V, Mayor A, Tschopp J. NALP inflammasomes: a central role in innate immunity. Seminars Immunopathol. 2007; 29(3):213–29. [DOI] [PubMed] [Google Scholar]
  • 7. Tian X, Pascal G, Monget P. Evolution and functional divergence of NLRP genes in mammalian reproductive systems. BMC Evol Biol. 2009; 9:202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Kufer TA, Sansonetti PJ. NLR functions beyond pathogen recognition. Nat Immunol. 2011; 12(2):121–8. [DOI] [PubMed] [Google Scholar]
  • 9. Tong ZB, Gold L, Pfeifer KE, Dorward H, Lee E, Bondy CA, et al. Mater, a maternal effect gene required for early embryonic development in mice. Nat Genet 2000; 26(3):267–8. [DOI] [PubMed] [Google Scholar]
  • 10. Dalbies‐Tran R, Papillier P, Pennetier S, Uzbekova S, Monget P. Bovine mater‐like NALP9 is an oocyte marker gene. Mol Reprod Dev. 2005; 71(4):414–21. [DOI] [PubMed] [Google Scholar]
  • 11. Ponsuksili S, Brunner RM, Goldammer T, Kuhn C, Walz C, Chomdej S, et al. Bovine NALP5, NALP8, and NALP9 genes: assignment to a QTL region and the expression in adult tissues, oocytes, and preimplantation embryos. Biol Reprod. 2006; 74(3):577–84. [DOI] [PubMed] [Google Scholar]
  • 12. Peng H, Zhang W, Xiao T, Zhang Y. Expression patterns of Nlrp9a, Nlrp9b and Nlrp9c during mouse development. Biologia. 2014; 69(1):107–112. [Google Scholar]
  • 13. Zhang P, Dixon M, Zucchelli M, Hambiliki F, Levkov L, Hovatta O, et al. Expression analysis of the NLRP gene family suggests a role in human preimplantation development. PLoS One 2008; 3(7):e2755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Hamatani T, Falco G, Carter MG, Akutsu H, Stagg CA, Sharov AA, et al. Age‐associated alteration of gene expression patterns in mouse oocytes. Hum Mol Genet. 2004; 13(19):2263–78. [DOI] [PubMed] [Google Scholar]
  • 15. Dade S, Callebaut I, Paillisson A, Bontoux M, Dalbies‐Tran R, Monget P. In silico identification and structural features of six new genes similar to MATER specifically expressed in the oocyte. Biochem Biophys Res Commun. 2004; 324(2):547–53. [DOI] [PubMed] [Google Scholar]
  • 16. Amoushahi M, Steffensen LL, Galieva A, Agger J, Heuck A, Siupka P, et al. Maternally contributed Nlrp9b expressed in human and mouse ovarian follicles contributes to early murine preimplantation development. J Assist Reprod Genet. 2020; 37(6):1355–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Peng H, Lin X, Liu F, Wang C, Zhang W. NLRP9B protein is dispensable for oocyte maturation and early embryonic development in the mouse. J Reprod Dev. 2015; 61(6):559–64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Wei Y, Li L, Zhou X, Zhang QY, Dunbar A, Liu F, et al. Generation and characterization of a novel Cyp2a(4/5)bgs‐null mouse model. Drug Metab Dispos. 2013; 41(1):132–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Kanzaki S, Tamura S, Ito T, Wakabayashi M, Saito K, Kato S, et al. Involvement of Nlrp9a/b/c in mouse preimplantation development. Reproduction 2020; 160(2):181–91. [DOI] [PubMed] [Google Scholar]
  • 20. Brubaker SW, Bonham KS, Zanoni I, Kagan JC. Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol. 2015; 33:257–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Mitchell PS, Sandstrom A, Vance RE. The NLRP1 inflammasome: new mechanistic insights and unresolved mysteries. Curr Opin Immunol. 2019; 60:37–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Lu A, Magupalli VG, Ruan J, Yin Q, Atianand MK, Vos MR, et al. Unified polymerization mechanism for the assembly of ASC‐dependent inflammasomes. Cell 2014; 156(6):1193–206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Cai X, Chen J, Xu H, Liu S, Jiang Q‐X, Halfmann R, et al. Prion‐like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 2014; 156(6):1207–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Broz P, Pelegrin P, Shao F. The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2020; 20(3):143–57. [DOI] [PubMed] [Google Scholar]
  • 25. Zhu S, Ding S, Wang P, Wei Z, Pan W, Palm NW, et al. Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells. Nature 2017; 546(7660):667–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Crawford SE, Ramani S, Tate JE, Parashar UD, Svensson L, Hagbom M, et al. Rotavirus infection. Nat Rev Dis Primers. 2017; 3:17083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Gross O. Measuring the inflammasome. Methods Mol Biol. 2012; 844:199–222. [DOI] [PubMed] [Google Scholar]
  • 28. Zhang B, Chassaing B, Shi Z, Uchiyama R, Zhang Z, Denning TL, et al. Viral infection. Prevention and cure of rotavirus infection via TLR5/NLRC4‐mediated production of IL‐22 and IL‐18. Science 2014; 346(6211):861–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Ramig RF. Pathogenesis of intestinal and systemic rotavirus infection. J Virol. 2004; 78(19):10213–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Ngo C, Man SM. NLRP9b: a novel RNA‐sensing inflammasome complex. Cell Res. 2017; 27(11):1302–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Marleaux M, Anand K, Latz E, Geyer M. Crystal structure of the human NLRP9 pyrin domain suggests a distinct mode of inflammasome assembly. FEBS Lett 2020; 594:2383–2395. [DOI] [PubMed] [Google Scholar]
  • 32. Ha HJ, Park HH. Crystal structure of the human NLRP9 pyrin domain reveals a bent N‐terminal loop that may regulate inflammasome assembly. FEBS Lett 2020; 594:2396–2405. [DOI] [PubMed] [Google Scholar]
  • 33. Ferrao R, Wu H. Helical assembly in the death domain (DD) superfamily. Curr Opin Struct Biol. 2012; 22(2):241–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Shen C, Lu A, Xie WJ, Ruan J, Negro R, Egelman EH, et al. Molecular mechanism for NLRP6 inflammasome assembly and activation. Proc Natl Acad Sci U S A. 2019; 116(6):2052–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Stutz A, Kolbe CC, Stahl R, Horvath GL, Franklin BS, van Ray O, et al. NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain. J Exp Med. 2017; 214(6):1725–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Lu A, Li Y, Yin Q, Ruan J, Yu X, Egelman E, et al. Plasticity in PYD assembly revealed by cryo‐EM structure of the PYD filament of AIM2. Cell Discov. 2015; 1:1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Yanling Q, Xiaoning C, Fei B, Liyun F, Huizhong H, Daqing S. Inhibition of NLRP9b attenuates acute lung injury through suppressing inflammation, apoptosis and oxidative stress in murine and cell models. Biochem Biophys Res Commun. 2018; 503(2):436–43. [DOI] [PubMed] [Google Scholar]
  • 38. Tadaki H, Saitsu H, Nishimura‐Tadaki A, Imagawa T, Kikuchi M, Hara R, et al. De novo 19q13.42 duplications involving NLRP gene cluster in a patient with systemic‐onset juvenile idiopathic arthritis. J Hum Genet. 2011; 56(5):343–7. [DOI] [PubMed] [Google Scholar]
  • 39. Gil‐Varea E, Urcelay E, Vilarino‐Guell C, Costa C, Midaglia L, Matesanz F, et al. Exome sequencing study in patients with multiple sclerosis reveals variants associated with disease course. J Neuroinflammation. 2018; 15(1):265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Fernandez MV, Budde J, Del‐Aguila JL, Ibanez L, Deming Y, Harari O, et al. Evaluation of gene‐based family‐based methods to detect novel genes associated with familial late onset alzheimer disease. Front Neurosci. 2018; 12:209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Poli G, Brancorsini S, Cochetti G, Barillaro F, Egidi MG, Mearini E. Expression of inflammasome‐related genes in bladder cancer and their association with cytokeratin 20 messenger RNA. Urol Oncol. 2015; 33(12):505.e1–e7. [DOI] [PubMed] [Google Scholar]
  • 42. Castano‐Rodriguez N, Kaakoush NO, Goh KL, Fock KM, Mitchell HM. The NOD‐like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer: a case‐control study and gene expression analyses. PLoS One 2014; 9(6):e98899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Wang P, Zhu S, Yang L, Cui S, Pan W, Jackson R, et al. Nlrp6 regulates intestinal antiviral innate immunity. Science 2015; 350(6262):826–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Nagyoszi P, Nyul‐Toth A, Fazakas C, Wilhelm I, Kozma M, Molnar J, et al. Regulation of NOD‐like receptors and inflammasome activation in cerebral endothelial cells. J Neurochem. 2015; 135(3):551–64. [DOI] [PubMed] [Google Scholar]
  • 45. Nyul‐Toth A, Kozma M, Nagyoszi P, Nagy K, Fazakas C, Hasko J, et al. Expression of pattern recognition receptors and activation of the non‐canonical inflammasome pathway in brain pericytes. Brain Behav Immun. 2017; 64:220–31. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

No data have been generated.


Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES